cordycepin has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Gao, XY; Liu, J; Liu, Y; Tian, YY; Wang, JH; Wang, Y; Xu, P; Xue, YM; Zhang, XM | 1 |
| Constantinou, A; Grdina, D; Huberman, E; Kiguchi, K | 1 |
2 other study(ies) available for cordycepin and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
| Article | Year |
|---|---|
Synergistic effect of HMGB1 knockdown and cordycepin in the K562 human chronic myeloid leukemia cell line.
Topics: Antineoplastic Agents; Apoptosis; Cell Adhesion; Cell Proliferation; Combined Modality Therapy; Cyclooxygenase 2; Deoxyadenosines; Gene Knockdown Techniques; HEK293 Cells; HMGB1 Protein; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Reactive Oxygen Species; Receptor for Advanced Glycation End Products; RNA, Small Interfering | 2015 |
The effect of topoisomerase inhibitors on the expression of differentiation markers and cell cycle progression in human K-562 leukemia cells.
Topics: Amsacrine; Aphidicolin; Cell Cycle; Cell Differentiation; Cycloheximide; Deoxyadenosines; Dose-Response Relationship, Drug; Etoposide; G2 Phase; Hemoglobins; Humans; Kinetics; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Melanins; Mitosis; Novobiocin; Teniposide; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1992 |